Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma

R Räty; T Honkanen; E Jantunen; M Lehto; A Rauhala; M Suominen

Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma

R Räty, T Honkanen, E Jantunen, M Lehto, A Rauhala, M Suominen

Research output: Contribution to journal › Article › Scientific › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	1920-1928
Journal	Leukemia & Lymphoma
Volume	53
Issue number	10
Publication status	Published - 2012
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://pubmed.ncbi.nlm.nih.gov/22397313

Cite this

Räty, R., Honkanen, T., Jantunen, E., Lehto, M., Rauhala, A., & Suominen, M. (2012). Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma. Leukemia & Lymphoma, 53(10), 1920-1928. https://pubmed.ncbi.nlm.nih.gov/22397313

@article{a64753a687664f71899f0abe6f841945,

title = "Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma",

author = "R R{\"a}ty and T Honkanen and E Jantunen and M Lehto and A Rauhala and M Suominen",

year = "2012",

language = "English",

volume = "53",

pages = "1920--1928",

number = "10",

}

Räty, R, Honkanen, T, Jantunen, E, Lehto, M, Rauhala, A & Suominen, M 2012, 'Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma', Leukemia & Lymphoma, vol. 53, no. 10, pp. 1920-1928. <https://pubmed.ncbi.nlm.nih.gov/22397313>

Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma. / Räty, R; Honkanen, T; Jantunen, E et al.
In: Leukemia & Lymphoma, Vol. 53, No. 10, 2012, p. 1920-1928.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma

AU - Räty, R

AU - Honkanen, T

AU - Jantunen, E

AU - Lehto, M

AU - Rauhala, A

AU - Suominen, M

PY - 2012

Y1 - 2012

M3 - Article

SN - 1042-8194

VL - 53

SP - 1920

EP - 1928

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - 10

ER -